Methadone is a prescription opioid medication used primarily for two purposes: treating opioid use disorder (OUD) and managing chronic pain. It has been in clinical use for more than 50 years, making it one of the longest-standing treatments for opioid addiction. Unlike short-acting opioids that produce rapid highs and crashes, methadone works slowly and steadily, which is what makes it effective for both of these very different medical needs.
Treating Opioid Use Disorder
Methadone’s most well-known role is as a maintenance medication for people with opioid use disorder. It works by activating the same receptors in the brain that heroin, fentanyl, and prescription painkillers target, but it does so gradually and at a controlled level. This prevents withdrawal symptoms and reduces cravings without producing the intense euphoria that drives addiction. The goal is stabilization: keeping a person functional, comfortable, and able to focus on recovery.
Methadone is one of three FDA-approved medications for OUD, alongside buprenorphine and naltrexone. In the United States, methadone for addiction treatment can only be dispensed through federally approved opioid treatment programs (OTPs), not through a regular pharmacy. This makes it different from buprenorphine, which can be prescribed in a standard doctor’s office.
Research comparing methadone and buprenorphine shows both are effective. In one prospective cohort study, about 8% of patients on buprenorphine were considered non-responders (meaning more than half their drug screens came back positive for non-prescribed opioids over a year), compared with roughly 12% on methadone. The study also found methadone was associated with higher treatment retention. In practice, the best medication depends on the individual’s history, tolerance level, and lifestyle.
Managing Chronic and Complex Pain
Methadone’s second major use is as a painkiller, particularly for chronic pain that hasn’t responded well to other opioids. It has a few properties that set it apart. Beyond activating opioid receptors, methadone also blocks a different type of receptor involved in how the nervous system amplifies pain signals over time. This dual action gives it a theoretical advantage for nerve-related pain and for patients who have developed tolerance to other opioids.
It’s also one of the few opioid painkillers that doesn’t need dose adjustments for people with kidney problems, since the body breaks it down into inactive byproducts rather than active ones that build up when the kidneys aren’t working well. Compared to morphine, methadone is significantly less expensive, lasts longer per dose, and is considered safer for patients with kidney failure. These characteristics make it a practical choice in palliative and end-of-life care settings.
What Treatment Looks Like Day to Day
For opioid use disorder, treatment typically starts with daily visits to an opioid treatment program. Traditional guidelines recommend a starting dose of no more than 30 mg, with gradual increases of 5 to 10 mg every few days. Under this approach, reaching a stable maintenance dose of 60 to 120 mg daily can take weeks to months. For patients whose primary drug is fentanyl, which builds extreme tolerance, updated 2024 regulations now allow first-day doses up to 50 mg with faster escalation to effective levels.
The daily clinic visits are one of the biggest practical hurdles. However, regulations have changed significantly in recent years. A 2024 federal rule made permanent the COVID-era flexibility allowing take-home doses from the first week of treatment, provided the clinical team judges it safe and appropriate. Patients who demonstrate stability can receive up to 28 days’ worth of take-home medication. The same rule also removed the requirement that patients receive counseling as a condition of getting their medication, though counseling is still offered and encouraged through a shared decision-making model.
Why Methadone’s Long Half-Life Matters
Methadone stays in the body far longer than most opioids. Its half-life ranges from 8 to 59 hours, with most people falling somewhere in the middle. This is what allows once-daily dosing for addiction treatment and provides steady pain relief without the peaks and valleys of shorter-acting drugs. But it also means the medication accumulates in the body over several days when you first start taking it. That accumulation period is when the risk of overdose is highest, which is why dose increases happen slowly and under close supervision.
Side Effects and Cardiac Risks
Common side effects are typical of opioids: constipation, sweating, drowsiness, nausea, and reduced sex drive. Most of these improve or become manageable over time as the body adjusts.
The more serious concern is methadone’s effect on heart rhythm. It can lengthen a specific part of the heartbeat cycle called the QT interval, which in rare cases triggers a dangerous irregular heartbeat. This risk increases at higher doses, in people with existing heart conditions, in those with low potassium or magnesium levels, and when methadone is combined with other medications that affect heart rhythm (certain antidepressants, antipsychotics, and antibiotics among them). Treatment programs evaluate patients for these risk factors before starting methadone, and heart rhythm monitoring is recommended for people on higher doses or with known risk factors.
Methadone During Pregnancy
Methadone is considered a standard treatment for pregnant women with opioid use disorder. Abruptly stopping opioids during pregnancy carries serious risks, including preterm labor, fetal distress, and miscarriage. Methadone maintenance keeps both the mother and fetus stable throughout pregnancy.
The tradeoff is that babies exposed to methadone in the womb often develop neonatal abstinence syndrome (NAS), a temporary withdrawal condition after birth. NAS is expected and treatable, and the CDC emphasizes that concern about it should not prevent providers from prescribing methadone to pregnant patients. Pediatric teams monitor newborns and provide treatment as needed. Breastfeeding is generally encouraged for mothers on methadone, and stopping the medication is discouraged in the postpartum period, at minimum until the baby is sleeping through the night and has finished breastfeeding.
Dangerous Interactions to Know About
Methadone interacts with a wide range of medications because the liver enzymes that break it down are the same ones that process many other drugs. Some medications speed up methadone’s breakdown, potentially triggering withdrawal symptoms. These include certain seizure medications, the antibiotic rifampicin, and some HIV medications. Other drugs slow methadone’s breakdown, causing levels to climb and increasing the risk of sedation, breathing problems, or heart rhythm changes. Certain antifungal medications and the antidepressant fluoxetine fall into this category.
The most dangerous combinations involve other substances that depress the central nervous system. Alcohol, benzodiazepines (like diazepam or lorazepam), and other opioids all multiply the risk of fatal respiratory depression when combined with methadone. This is the single most important safety consideration for anyone taking the medication.